
Immunology


Individualized follow-up of COVID-19 vaccine for some HIV patients

Immune response protein is involved in embryonic development

A step closer to personalising multiple sclerosis treatment

Discovered a new mechanism against Epstein-Barr virus infection

Antibodies against SARS-CoV-2 remain stable seven months after the infection

Immunity anniversary: antibodies against SARS-CoV-2 remain one year after infection

Launched a clinical trial to prevent the side effects of COVID-19

SARS-Cov-2 antibodies detected three months after the infection

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients
